PFAS : an overview of the science and guidance for clinicians on per- and polyfluoroalkyl substances (PFAS)

Details

• Corporate Authors:
  United States. Agency for Toxic Substances and Disease Registry.
• Description:
  Revised 12/6/2019
  
  This document provides an overview of what is known about per-and polyfluoroalkyl substances (PFAS) and identifies health effects associated with PFAS exposure. The following information will help clinicians respond to patient concerns about PFAS exposure. The document is divided into four sections:
  
  1. PFAS basics,
  
  2. PFAS health studies,
  
  3. questions patients may ask clinicians about PFAS, and
  
  4. where to find additional PFAS resources and references.
  
  Understanding potential health issues associated with PFAS exposure is an ongoing collaborative effort of federal, state, tribal, and local governments.
  
  New research PFAS is growing quickly; to learn the latest about CDC/ATSDR work on PFAS, visit https://www.atsdr.cdc.gov/pfas/related_activities.html.
  
  ATSDR_PFAS_ClinicalGuidance_12202019.pdf
  
  
• Subjects:
  Environmental Pollutants/toxicity Fluorocarbons/adverse Effects Fluorocarbons/toxicity
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Guidance
• Pages in Document:
  21 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:8106d772e7c354a7054fb69f0456f00530e8a59e09cb00b194e76742ca792421
• Download URL:
  https://stacks.cdc.gov/view/cdc/84242/cdc_84242_DS1.pdf
• File Type:
  [PDF - 339.94 KB ]